What the public record says
The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record.
What buyers should check
- Peptide Clinics Pty Ltd remains the benchmark Australian peptide-advertising case because the Federal Court ordered a $10 million civil penalty.
- Your Solution Compounding Pharmacy is included as an adjacent GLP-1 and compounded-weight-loss advertising undertaking, not a peptide-vendor fine.
- The April 2024 Victorian case is the peptide-specific import infringement in this tracker.
- The September 2025 Victorian case involved modafinil and armodafinil, not peptides, and is included as repeat personal-import enforcement context.
- The December 2025 NSW case and January 2026 6-individual case are cosmetic-injectable and unapproved-therapeutic-goods enforcement context.
- Switch Nutrition is included as therapeutic-goods advertising enforcement involving prohibited representations, not as a peptide vendor page.
- The 2022 NSW medical-practitioner import case is included as a personal-import and prescription-only import warning, not a peptide-specific case.
- Caruso's Natural Health is included because it shows mainstream listed-medicine sponsors can be penalised when evidence behind therapeutic uses is not held.
- No vendor-specific TGA penalty is applied unless the vendor page links the public source directly.
Tracker table
23 July 2019 - Peptide advertising and prescription-only medicines. Benchmark case for clinic-model peptide advertising and implied medical oversight.
TGA $10 million Peptide Clinics penalty2024 advertising period, undertaking published later - Compounded weight-loss medicine advertising. Clinic-model and GLP-1 advertising compliance context.
TGA Your Solution Compounding Pharmacy undertaking29 April 2024 - Peptide import infringement. Peptide-specific personal-import enforcement context.
TGA Victorian peptide import notice25 September 2025 - Prescription-only medicine import infringement. Repeat personal-import enforcement context; TGA names modafinil and armodafinil, not peptides.
TGA Victorian further notices18 December 2025 - Cosmetic-injectable and prescription-only medicine import infringement. Adjacent import-risk context for injectables and unapproved prescription-only medicines.
TGA NSW cosmetic injectables import notice29 January 2026 - Unapproved therapeutic-goods import and advertising infringement. Broader import, counterfeit, and unlawful advertising context for therapeutic goods.
TGA 6 individuals infringement notices28 April 2026 - Therapeutic-goods advertising infringement. Advertising and prohibited-representation context for wellness and supplement-style claims.
TGA Switch Nutrition infringement notices18 October 2022 - Prescription-only medicine import infringement. Personal-import and prescription-only medicine import context; not a peptide-specific case.
TGA NSW $2,664 import infringement13 March 2024 - Listed-medicine evidence requirements. Mainstream sponsor evidence-context: even listed-medicine therapeutic-use claims need supporting evidence.
TGA Caruso's Natural Health infringement noticesSource links
- TGA $10 million Peptide Clinics penalty
- TGA Your Solution Compounding Pharmacy undertaking
- TGA Victorian peptide import notice
- TGA Victorian further notices
- TGA NSW cosmetic injectables import notice
- TGA 6 individuals infringement notices
- TGA Switch Nutrition infringement notices
- TGA NSW $2,664 import infringement
- TGA Caruso's Natural Health infringement notices
Use this regulatory brief to ask better supplier questions. Do not convert a market-level warning into a vendor-specific claim unless the vendor page has a source attached.
Open vendor scorecards